Medina-Prado Lucía, Hassan Cesare, Dekker Evelien, Bisschops Raf, Alfieri Sergio, Bhandari Pradeep, Bourke Michael J, Bravo Raquel, Bustamante-Balen Marco, Dominitz Jason, Ferlitsch Monika, Fockens Paul, van Leerdam Monique, Lieberman David, Herráiz Maite, Kahi Charles, Kaminski Michal, Matsuda Takahisa, Moss Alan, Pellisé Maria, Pohl Heiko, Rees Colin, Rex Douglas K, Romero-Simó Manuel, Rutter Matthew D, Sharma Prateek, Shaukat Aasma, Thomas-Gibson Siwan, Valori Roland, Jover Rodrigo
Servicio de Medicina Digestiva, Hospital General Universitario de Alicante, Instituto de Investigación Biomédica Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain.
Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy.
Clin Gastroenterol Hepatol. 2021 May;19(5):1038-1050. doi: 10.1016/j.cgh.2021.01.024. Epub 2021 Jan 22.
BACKGROUND & AIMS: There is a lack of clinical studies to establish indications and methodology for tattooing, therefore technique and practice of tattooing is very variable. We aimed to establish a consensus on the indications and appropriate techniques for colonic tattoo through a modified Delphi process.
The baseline questionnaire was classified into 3 areas: where tattooing should not be used (1 domain, 6 questions), where tattooing should be used (4 domains, 20 questions), and how to perform tattooing (1 domain 20 questions). A total of 29 experts participated in the 3 rounds of the Delphi process.
A total of 15 statements were approved. The statements that achieved the highest agreement were as follows: tattooing should always be used after endoscopic resection of a lesion with suspicion of submucosal invasion (agreement score, 4.59; degree of consensus, 97%). For a colorectal lesion that is left in situ but considered suitable for endoscopic resection, tattooing may be used if the lesion is considered difficult to detect at a subsequent endoscopy (agreement score, 4.62; degree of consensus, 100%). A tattoo should never be injected directly into or underneath a lesion that might be removed endoscopically at a later point in time (agreement score, 4.79; degree of consensus, 97%). Details of the tattoo injection should be stated clearly in the endoscopy report (agreement score, 4.76; degree of consensus, 100%).
This expert consensus has developed different statements about where tattooing should not be used, when it should be used, and how that should be done.
目前缺乏确定纹身适应证和方法的临床研究,因此纹身技术和实践差异很大。我们旨在通过改良的德尔菲法就结肠纹身的适应证和合适技术达成共识。
基线调查问卷分为3个领域:纹身不应使用的情况(1个领域,6个问题)、纹身应使用的情况(4个领域,20个问题)以及如何进行纹身(1个领域,20个问题)。共有29位专家参与了3轮德尔菲法。
共批准了15项声明。达成最高共识的声明如下:对于怀疑有黏膜下浸润的病变进行内镜切除后应始终使用纹身(共识得分4.59;共识程度97%)。对于原位保留但被认为适合内镜切除的结直肠病变,如果该病变在后续内镜检查中被认为难以发现,则可使用纹身(共识得分4.62;共识程度100%)。绝不应将纹身剂直接注射到或注射在以后可能通过内镜切除的病变内或其下方(共识得分4.79;共识程度97%)。纹身注射的详细情况应在内镜检查报告中明确说明(共识得分4.76;共识程度100%)。
本专家共识针对纹身不应使用的情况、应使用的时机以及操作方式制定了不同的声明。